Human recombinant soluble ACE2 in severe COVID-19

Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / blood
  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus
  • Biomarkers / blood
  • COVID-19
  • Coronavirus Infections / therapy*
  • Female
  • Humans
  • Middle Aged
  • Pandemics
  • Peptidyl-Dipeptidase A / therapeutic use*
  • Pneumonia, Viral / therapy*
  • Recombinant Proteins / therapeutic use*
  • SARS-CoV-2

Substances

  • Biomarkers
  • Recombinant Proteins
  • Angiotensin II
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2